NP-1031 is an oxytocin receptor modulator which is under development for the treatment of Prader–Willi syndrome. Its route of administration has not been specified.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.